What's in Ascletis Pharmaceuticals Co., Ltd.'s pipeline?

Ascletis Pharmaceuticals Co., Ltd. has 10 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 2 in Phase 2, 6 in Phase 1.

Which companies overlap with Ascletis Pharmaceuticals Co., Ltd.'s portfolio?

Top competitors by shared drug class: Assistance Publique Hopitaux De Marseille, AstraZeneca, Biocad, CStone Pharmaceuticals, Celltrion.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ascletis-pharmaceuticals-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Ascletis Pharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief

Ascletis Pharmaceuticals Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 2 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ASC40	ASC40	phase 3	HBV capsid assembly inhibitor	HBV core antigen (HBcAg)	Virology / Hepatology
ASC40 tablets	ASC40 tablets	phase 3	HBV capsid assembly inhibitor	HBV core antigen (capsid assembly)	Virology / Hepatology

Therapeutic area mix

Virology / Hepatology · 2
Gastroenterology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique Hopitaux De Marseille · 1 shared drug class
AstraZeneca · 1 shared drug class
Biocad · 1 shared drug class
CStone Pharmaceuticals · 1 shared drug class
Celltrion · 1 shared drug class
Clovis Oncology, Inc. · 1 shared drug class
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. · 1 shared drug class
3D Medicines (Sichuan) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ascletis Pharmaceuticals Co., Ltd.:

Cite this brief

Drug Landscape (2026). Ascletis Pharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ascletis-pharmaceuticals-co-ltd. Accessed 2026-05-16.